RND3 and glioblastoma: Accordingly, we show that Rnd3 silencing reduces GBM cell motility and invasion, resulting in cytoskeletal reorganization characterised by increased actomyosin contractility and cellular adhesion that recapitulates the phenotype observed upon RTK inhibition.